We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

900947:SSEShanghai Zhenhua Heavy Industries Co., Ltd. Class B Analysis

Data as of 2026-03-17 - not real-time

$0.26

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Shanghai Zhenhua Heavy Industries (900947.SS) is the world’s largest port‑machinery maker and is positioning automated container terminals as its next growth engine. Revenue grew 5.9% YoY to ¥35.1 bn, but margins remain thin (gross 11.7%, operating 4.5%) and the balance sheet is highly leveraged (debt‑to‑equity ≈ 127). Dividend yield stands at 3.97% with a payout ratio of 46.9%, suggesting a relatively sustainable payout given a free‑cash‑flow of ¥2.7 bn.
On the valuation side, the stock trades at ¥0.263, far below the DCF‑derived fair value of ¥2.85 and well under the industry average PE of 29 (its PE is 13). Technical signals show the price perched at a key support of ¥0.263, a modest RSI of 36 and a bearish MACD histogram, while volume is rising. The ultra‑low beta (0.015) and a 30‑day volatility of 13% indicate limited price swings, but the heavy debt load and exposure to Chinese policy add a layer of risk. Overall, the stock appears deeply undervalued with a strong dividend appeal, yet investors should monitor leverage and the execution of its automation strategy.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Price at technical support level
  • High dividend yield with sustainable payout
  • Significant valuation gap to DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic push into automated terminals
  • Undervalued relative to peers
  • Stable cash flow supporting dividend

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term growth potential in smart‑port infrastructure
  • Consistently low beta and modest volatility
  • Attractive valuation and dividend yield

Key Metrics & Analysis

Financial Health

Revenue Growth5.90%
Profit Margin1.78%
P/E Ratio13.2
ROE4.63%
ROA0.55%
Debt/Equity127.30
P/B Ratio0.6
Op. Cash Flow$6.0B
Free Cash Flow$2.7B
Industry P/E29.3

Technical Analysis

TrendNeutral
RSI36.1
Support$0.26
Resistance$0.28
MA 20$0.27
MA 50$0.27
MA 200$0.27
MACDBearish
VolumeIncreasing
Fear & Greed Index79.45

Valuation

Fair Value$2.85
GradeUndervalued
TypeValue
Dividend Yield3.97%

Risk Assessment

Beta0.02
Volatility13.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.